Filter Results:
(3,320)
Show Results For
- All HBS Web
(3,320)
- People (7)
- News (456)
- Research (2,506)
- Events (11)
- Multimedia (13)
- Faculty Publications (1,531)
Show Results For
- All HBS Web
(3,320)
- People (7)
- News (456)
- Research (2,506)
- Events (11)
- Multimedia (13)
- Faculty Publications (1,531)
- 09 Nov 2012
- Working Paper Summaries
Securities Litigation Risk for Foreign Companies Listed in the US
- September 2010 (Revised May 2012)
- Case
Harvard Management Company (2010)
By: Andre F. Perold and Erik Stafford
In February 2010, Jane Mendillo, CEO of Harvard Management Company, was reflecting on the list of issues facing Harvard University's endowment in preparation for the upcoming board meeting. The recent financial crisis had vividly highlighted several key issues... View Details
Keywords: Financial Crisis; Higher Education; Asset Management; Financial Liquidity; Investment Portfolio; Risk Management; Education Industry; Financial Services Industry; Massachusetts
Perold, Andre F., and Erik Stafford. "Harvard Management Company (2010)." Harvard Business School Case 211-004, September 2010. (Revised May 2012.)
- 10 Dec 2021
- Research & Ideas
Truth Be Told: Unpacking the Risks of Whistleblowing
In 2018, HBS associate professors Aiyesha Dey and Jonas Heese wrote a case about a whistleblower at a multi-national gambling company who exposed financial misstatements, first to his manager and later to the US Securities and Exchange... View Details
Keywords: by April White
- February 2019
- Article
Who Benefits Most in Disease Management Programs: Improving Target Efficiency
By: Timothy Simcoe, Maryaline Catillon and Paul Gertler
Disease management programs aim to reduce cost by improving the quality of care for chronic diseases. Evidence of their effectiveness is mixed. Reducing health care spending sufficiently to cover program costs has proved particularly challenging. This study uses a... View Details
Keywords: Health Economics; Target Efficiency; Diabetes; Disease Management; Program Evaluation; Heterogeneity; Economics; Health; Quality; Health Care and Treatment; Cost Management; Health Industry
Simcoe, Timothy, Maryaline Catillon, and Paul Gertler. "Who Benefits Most in Disease Management Programs: Improving Target Efficiency." Health Economics 28, no. 2 (February 2019): 189–203.
- April 2023
- Case
Strive Asset Management
By: Suraj Srinivasan, Lynn S. Paine and Aldo Sesia
Strive Asset Management, which launched in 2022, was actively targeting several leading U.S. companies in the upcoming 2023 proxy voting season to stop acquiescing to those large asset managers and other institutional shareholders who were pressing those companies to... View Details
- March 2006
- Background Note
Strategic Compliance Management
Explains the construct of strategic compliance management (SCM) and asserts that managers and their firms can perform more effectively, that is, create or capture more value or better manage risk, when they comply with applicable laws, search for innovation... View Details
Bagley, Constance E. "Strategic Compliance Management." Harvard Business School Background Note 806-173, March 2006.
- Program
Investment Management Workshop
Summary The Investment Management Workshop convenes the world's top principals, portfolio managers, and executives to explore the latest industry strategies and best practices. Focused on asset management, business strategy, business... View Details
- January 1998
- Article
Risk Management, Capital Budgeting and Capital Structure Policy for Financial Institutions: An Integrated Approach
By: K. A. Froot and J. Stein
Keywords: Catastrophe Risk; Corporate Finance; Cost Of Capital; Banking And Insurance; Asset Pricing; Hedging; Banking; Decision Choice And Uncertainty; Financial Markets; Insurance; Policy; Risk Management; Natural Disasters; Insurance Industry
Froot, K. A., and J. Stein. "Risk Management, Capital Budgeting and Capital Structure Policy for Financial Institutions: An Integrated Approach." Journal of Financial Economics 47, no. 1 (January 1998): 55–82. (Winner of Journal of Financial Economics. Jensen Prize. First Place For the best paper published in the Journal of Financial Economics in the areas of corporate finance and organizations. Revised from NBER Working Paper No. 5403, January 1996 and HBS Working Paper 96-030, December 1995.)
- October 2021
- Article
Shareholder Activism and Firms' Voluntary Disclosure of Climate Change Risks
By: Caroline Flammer, Michael W. Toffel and Kala Viswanathan
This paper examines whether—in the absence of mandated disclosure requirements—shareholder activism can elicit greater disclosure of firms’ exposure to climate change risks. We find that environmental shareholder activism increases the voluntary disclosure of climate... View Details
Keywords: Transparency; Reporting; Shareholder Engagement; Shareholder Activism; Climate Change; Risk and Uncertainty; Environmental Management; Investment Activism; Corporate Disclosure; Communication Strategy; Information Publishing; Measurement and Metrics; Corporate Social Responsibility and Impact; Problems and Challenges; United States
Flammer, Caroline, Michael W. Toffel, and Kala Viswanathan. "Shareholder Activism and Firms' Voluntary Disclosure of Climate Change Risks." Strategic Management Journal 42, no. 10 (October 2021): 1850–1879. (Featured in Harvard Business Review.)
- 09 May 2005
- Research & Ideas
Hold or Fold? Sizing Up Business Risk
disappointed in the performance of the company. You think the technology is solid but the management team, and particularly the CEO, isn't very strong. The board has begun to take a more active role, the founder-CEO has been made the... View Details
- March 2011
- Case
Grand Circle Travel: Where Risk Comes with the Territory
A worldwide travel company is intrinsically exposed to risks of natural and man-made disasters. How do you organize a business for success when it must on a nearly daily basis cope with hazards ranging from minor mishaps to large-scale catastrophes? Alan and Harriet... View Details
Keywords: Crisis Management; Risk and Uncertainty; Safety; Transportation; Organizational Design; Decision Choices and Conditions; Organizational Structure; Mission and Purpose; Competitive Advantage; Travel Industry
Leonard, Herman B. "Grand Circle Travel: Where Risk Comes with the Territory." Harvard Business School Case 311-105, March 2011.
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
survival is at risk. In business there is failure all the time. Our colleague Dorothy Leonard Barton developed the phrase “failing forward” to describe how innovative firms always take risks but learn from their failures. The trick as our... View Details
Keywords: by Martha Lagace
- 16 Sep 2019
- Research & Ideas
Crowdsourcing Is Helping Hollywood Reduce the Risk of Movie-Making
industries like biotech, you can test things along the way to see if they are feasible, but for creative ideas like a film, you can’t experiment. You have huge uncertainty and you have to think about how to manage that risk.” One way that... View Details
- October 2008
- Article
Risk Frameworks and Biomonitoring: Distributed Regulation of Synthetic Chemicals in Humans
By: Arthur A. Daemmrich
The ability to detect and measure the presence of synthetic chemicals at trace levels in humans coupled to increased environmental NGO mobilization concerning chemical exposure has challenged risk and regulatory frameworks built up over the past quarter-century. This... View Details
Keywords: Chemicals; Governing Rules, Regulations, and Reforms; Risk Management; Natural Environment; Pollutants; Non-Governmental Organizations; United States
Daemmrich, Arthur A. "Risk Frameworks and Biomonitoring: Distributed Regulation of Synthetic Chemicals in Humans." Environmental History 13, no. 4 (October 2008): 684–694.
- 18 Jun 2018
- Working Paper Summaries
A Measure of Risk Appetite for the Macroeconomy
- 1997
- Other Unpublished Work
Maximizing Corporate Shareholder Value Using Risk Profile Dynamics
By: Marc L Bertoneche and Samir Asaf
- 17 Oct 2024
- Research & Ideas
The Reputation Risks of Sharing Fake News
Social Change Lab at Stanford University; Robb Willer, professor of sociology at Stanford University; Mohsen Mosleh, associate professor at the University of Oxford; Gordon Pennycook, associate professor at Cornell University; and David Rand, professor of View Details
Keywords: by Avery Forman
- November 2019
- Article
Procedural Justice and the Risks of Consumer Voting
By: Tami Kim, Leslie John, Todd Rogers and Michael I. Norton
Firms are increasingly giving consumers the vote. Eight studies demonstrate that when firms empower consumers to vote, consumers infer a series of implicit promises—even in the absence of explicit promises. We identify three implicit promises to which consumers react... View Details
Keywords: Consumer Empowerment; Procedural Justice; Promises; Customer Relationship Management; Voting; Perception; Fairness; Risk Management
Kim, Tami, Leslie John, Todd Rogers, and Michael I. Norton. "Procedural Justice and the Risks of Consumer Voting." Management Science 65, no. 11 (November 2019): 5234–5251.
- 09 Jul 2024
- Research & Ideas
Are Management Consulting Firms Failing to Manage Themselves?
distributed, independent partners with the centralized oversight needed to manage growth, ensure risk compliance, and maintain firm cultures. Embrace the return to meritocracy while (re)building internal... View Details
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details
Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Pharmaceutical Industry; Health Industry; United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.